Wheler, Jennifer J <br/><br/>
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms.  [electronic resource] 

 -  Oncotarget  May 2014 
 - 2349-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.1946  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Female<br/>Genes, Neoplasm<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Molecular Targeted Therapy<br/>Neoplasm Proteins--genetics